Thus, pathologically expressed TF may provide a target for the development of novel cancer therapies that are effective not only against tumour cells but also against tumour blood vessels (Hu et al, 1999; Hu and Garen, 2000, 2001; Alessi et al, 2004). This evidence concerns the gene TF and cancer.